Neuron-derived IgG protects dopaminergic neurons from insult by 6-OHDA and activates microglia through the FcγR i and TLR4 pathways

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 8, 2013, Pages 1911-1920

  Zhang, Jie ^a   Niu, Na ^a   Wang, Mingyu ^a   McNutt, Michael A ^b   Zhang, Donghong ^c   Zhang, Baogang ^a   Lu, Shijun ^a   Liu, Yuqing ^a   Liu, Zhihui ^a  

^a WEIFANG MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Fc R I; Microglia; Neuron derived IgG; Parkinson's disease; TLR4

Indexed keywords

FC GAMMA RECEPTOR I; FC RECEPTOR; IMMUNOGLOBULIN G; INTERLEUKIN 10; NITRIC OXIDE; OXIDOPAMINE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOTOXICITY; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MALE; MESENCEPHALON; MICROGLIA; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; RAT; SUBSTANTIA NIGRA;

RATTUS;

EID: 84880183029     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.06.005     Document Type: Article

References (48)

1. Akira S. Toll-like receptor signaling. Journal of Biological Chemistry 2003;278:38105-8. (Pubitemid 37221695)
2. Arimoto T, Bing G. Up-regulation of inducible nitric oxide synthase in the substantianigra by lipopolysaccharide causes microglial activation and neurodegenera-tion. Neurobiology of Disease 2003;12:35-45. (Pubitemid 36259966)
3. Arumugam TV, Tang SC, Lathia JD, Cheng A, Mughal MR, Chigurupati S, et al. Intravenous immunoglobulin (IVIG) protects the brain against experimentalstroke by preventing complement-mediated neuronal cell death. Proceedingsof the National Academy of Sciences of the United States of America 2007;104:14104-9. (Pubitemid 350003342)
4. Barnum CJ, Tansey MG. Modeling neuroinflammatory pathogenesis of Parkinson'sdisease. Progress in Brain Research 2010;184:113-32.
5. Blanco AM, Valles SL, Pascual M, Guerri C. Involvement of TLR4/type I IL-1 receptorsignaling in the induction of inflammatory mediators and cell death induced byethanol in cultured astrocytes. Journal of Immunology 2005;175:6893-9. (Pubitemid 41599911)
6. Bosmann M, Haggadone MD, Hemmila MR, Zetoune FS, Sarma JV, Ward PA. Comple-ment activation product C5a is a selective suppressor of TLR4-induced, but notTLR3-induced, production of IL-27(p28) from macrophages. Journal of Immunol-ogy 2012;188:5086-93.
7. Bournival J, Plouffe M, Renaud J, Provencher C, Martinoli MG. Quercetin andsesamin protect dopaminergic cells from MPP+-induced neuroinflammation ina microglial (N9)-neuronal (PC12) coculture system. Oxidative Medicine andCellular Longevity 2012;2012:921941.
8. Caggiano AO, Kraig RP. Prostaglandin E receptor subtypes in cultured rat microgliaand their role in reducing lipopolysaccharide-induced interleukin-1beta pro-duction. Journal of Neurochemistry 1999;72:565-75. (Pubitemid 29055218)
9. Cao S, Standaert DG, Harms AS. The gamma chain subunit of Fc receptors is requiredfor alpha-synuclein-induced pro-inflammatory signaling in microglia. Journalof Neuroinflammation 2012;9:259.
10. Cao S, Theodore S, Standaert DG. Fcgamma receptors are required for NF-kappaBsignaling, microglial activation and dopaminergic neurodegeneration in anAAV-synuclein mouse model of Parkinson's disease. Molecular Neurodegener-ation 2010;5:42.
11. Floden AM, Li S, Combs CK. Beta-amyloid-stimulated microglia induce neuron deathvia synergistic stimulation of tumor necrosis factor alpha and NMDA receptors. Journal of Neuroscience 2005;25:2566-75. (Pubitemid 40365168)
12. Gao HM, Hong JS. Why neurodegenerative diseases are progressive: uncon-trolled inflammation drives disease progression. Trends in Immunology 2008;29:357-65.
13. Gao HM, Hong JS, Zhang W, Liu B. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. Journal of Neuroscience 2002;22:782-90. (Pubitemid 34141759)
14. Gerber JS, Mosser DM. Reversing lipopolysaccharide toxicity by ligating themacrophage Fc gamma receptors. Journal of Immunology 2001;166:6861-8. (Pubitemid 32467232)
15. Goldman D, Song X, Kitai R, Casadevall A, Zhao ML, Lee SC. Cryptococcus neoformansinduces macrophage inflammatory protein 1alpha (MIP-1alpha) and MIP-1betain human microglia: role of specific antibody and soluble capsular polysaccha-ride. Infection and Immunity 2001;69:1808-15. (Pubitemid 32187640)
16. Gruden MA, Yanamandra K, Kucheryanu VG, Bocharova OR, Sherstnev VV,Morozova-Roche LA, et al. Correlation between protective immunity toalpha-synuclein aggregates, oxidative stress and inflammation. Neuroim-munomodulation 2012;19:334-42.
17. Hirsch EC, Hunot S. Neuroinflammation in Parkinson's disease: a target for neuro-protection? Lancet Neurology 2009;8:382-97.
18. Huang J, Sun X, Mao Y, Zhu X, Zhang P, Zhang L, et al. Expression of immunoglobulingene with classical V-(D)-J rearrangement in mouse brain neurons. International Journal of Biochemistry & Cell Biology 2008;40:1604-15.
19. Hulse RE, Swenson WG, Kunkler PE, White DM, Kraig RP. Monomeric IgG is neuropro-tective via enhancing microglial recycling endocytosis and TNF-alpha. Journalof Neuroscience 2008;28:12199-211.
20. Kennedy PG, Lisak RP, Raff MC. Cell type-specific markers for human glial and neu-ronal cells in culture. Laboratory Investigation 1980;43:342-51. (Pubitemid 10008960)
21. Kim DC, Kim SH, Jeong MW, Baek NI, Kim KT. Effect of rottlerin, a PKC-delta inhibitor,on TLR-4-dependent activation of murine microglia. Biochemical and Biophys-ical Research Communications 2005;337:110-5.
22. Kunkler PE, Hulse RE, Kraig RP. Multiplexed cytokine protein expression profilesfrom spreading depression in hippocampal organotypic cultures. Journal ofCerebral Blood Flow & Metabolism 2004;24:829-39. (Pubitemid 39045400)
23. Li YN, Qin XJ, Kuang F, Wu R, Duan XL, Ju G, et al. Alterations of Fc gamma receptor Iand Toll-like receptor 4 mediate the antiinflammatory actions of microglia andastrocytes after adrenaline-induced blood-brain barrier opening in rats. Journalof Neuroscience Research 2008;86:3556-65.
24. Matsui T, Tasaki M, Yoshioka T, Motoki Y, Tsuneoka H, Nojima J. Temperature- andtime-dependent changes in TLR2-activated microglial NF-kappaB activity andconcentrations of inflammatory and anti-inflammatory factors. Intensive Care Medicine 2012;38:1392-9.
25. McGeer PL, McGeer EG. Glial reactions in Parkinson's disease. Movement Disorders 2008;23:474-83.
26. Montgomery SL, Bowers WJ. Tumor necrosis factor-alpha and the roles it plays inhomeostatic and degenerative processes within the central nervous system. Journal of Neuro Immune Pharmacology 2012;7:42-59.
27. Murray RZ, Kay JG, Sangermani DG, Stow JL. A role for the phagosome in cytokinesecretion. Science 2005;310:1492-5.
28. Nakahara J, Tan-Takeuchi K, Seiwa C, Gotoh M, Kaifu T, Ujike A, et al. Signaling viaimmunoglobulin Fc receptors induces oligodendrocyte precursor cell differen-tiation. Developmental Cell 2003;4:841-52. (Pubitemid 36676036)
29. Nimmerjahn A, Kirchhoff F, Helmchen F. Resting microglial cells are highly dynamicsurveillants of brain parenchyma in vivo. Science 2005;308:1314-8. (Pubitemid 40746128)
30. Niu N, Zhang J, Guo Y, Yang C, Gu J. Cystic fibrosis transmembrane conductanceregulator expression in human spinal and sympathetic ganglia. Laboratory Investigation 2009;89:636-44.
31. Niu N, Zhang J, Guo Y, Zhao Y, Korteweg C, Gu J. Expression and distribution ofimmunoglobulin G and its receptors in the human nervous system. International Journal of Biochemistry & Cell Biology 2011a;43:556-63.
32. Niu N, Zhang J, Huang T, Sun Y, Chen Z, Yi W, et al. IgG expression in human colo-rectal cancer and its relationship to cancer cell behaviors. PLoS ONE 2012;7:e 47362.
33. Niu N, Zhang J, Sun Y, Wang S, Sun Y, Korteweg C, et al. Expression and distributionof immunoglobulin G and its receptors in an immune privileged site: the eye. Cellular and Molecular Life Sciences 2011b;68:2481-92.
34. Okada H, Imai M, Ono F, Okada A, Tada T, Mizue Y, et al. Novel complementarypeptides to target molecules. Anticancer Research 2011;31:2511-6.
35. Olson JK, Miller SD. Microglia initiate central nervous system innate and adap-tive immune responses through multiple TLRs. Journal of Immunology 2004;173:3916-24. (Pubitemid 39280755)
36. Panaro MA, Cianciulli A. Current opinions and perspectives on the role of immunesystem in the pathogenesis of Parkinson's disease. Current Pharmaceutical Design 2012;18:200-8.
37. Raghavan M, Bjorkman PJ. Fc receptors and their interactions with immunoglobu-lins. Annual Review of Cell and Developmental Biology 1996;12:181-220.
38. Rittirsch D, Flierl MA, Day DE, Nadeau BA, Zetoune FS, Sarma JV, et al. Cross-talkbetween TLR4 and Fcgamma receptor III (CD16) pathways. PLoS Pathogens 2009;5:e 1000464.
39. Silva SL, Vaz AR, Diogenes MJ, van Rooijen N, Sebastiao AM, Fernandes A, et al. Neu-ritic growth impairment and cell death by unconjugated bilirubin is mediated byNO and glutamate, modulated by microglia, and prevented by glycoursodeoxy-cholic acid and interleukin-10. Neuropharmacology 2012;62:2398-408.
40. Solesio ME, Saez-Atienzar S, Jordan J, Galindo MF. Characterization of mitophagyin the 6-hydoxydopamine Parkinson's disease model. Toxicological Sciences 2012;129:411-20.
41. Song X, Shapiro S, Goldman DL, Casadevall A, Scharff M, Lee SC. Fcgamma receptor I-and III-mediated macrophage inflammatory protein 1alpha induction in primaryhuman and murine microglia. Infection and Immunity 2002;70:5177-84.
42. Tufekci KU, Meuwissen R, Genc S, Genc K. Inflammation in Parkinson's disease. Advances in Protein Chemistry and Structural Biology 2012;88:69-132.
43. Upender MB, Dunn JA, Wilson SM, Naegele JR. Immunoglobulin molecules arepresent in early-generated neuronal populations in the rat cerebral cortex andretina. Journal of Comparative Neurology 1997;384:271-82. (Pubitemid 27282043)
44. Wang XJ, Yan ZQ, Lu GQ, Stuart S, Chen SD. Parkinson disease IgG and C5a-inducedsynergistic dopaminergic neurotoxicity: role of microglia. Neurochemistry International 2007;50:39-50. (Pubitemid 44895357)
45. Weiner JA, Chun J. Maternally derived immunoglobulin light chain ispresent in the fetal mammalian CNS. Journal of Neuroscience 1997;17:3148-56. (Pubitemid 27175827)
46. Wilde GJ, Pringle AK, Sundstrom LE, Mann DA, Iannotti F. Attenuation and augmen-tation of ischaemia-related neuronal death by tumour necrosis factor-alpha invitro. European Journal of Neuroscience 2000;12:3863-70.
47. Zhang D, Chen Y, Xie X, Liu J, Wang Q, Kong W, et al. Homocysteine activates vascularsmooth muscle cells by DNA demethylation of platelet-derived growth fac-tor in endothelial cells. Journal of Molecular and Cellular Cardiology 2012a;53:487-96.
48. Zhang LJ, Xue YQ, Yang C, Yang WH, Chen L, Zhang QJ, et al. Human albumin prevents6-hydroxydopamine-induced loss of tyrosine hydroxylase in in vitro and in vivo.PLoS ONE 2012b;7:e 41226.